What is testosterone cypionate 200 mg injection used for?
Testosterone cypionate is an injectable form of testosterone, a synthetic version of the primary male sex hormone. It is used to treat low testosterone levels in men, including hypogonadism, delayed puberty, and certain types of hypogonadism [1]. Testosterone replacement therapy aims to restore testosterone levels to a normal range, alleviating symptoms such as low libido, fatigue, and decreased muscle mass [1, 2].
How is testosterone cypionate 200 mg injection administered?
Testosterone cypionate injection is given via intramuscular injection, typically every 1-4 weeks, depending on the individual's dosage and treatment plan [3]. The injection is usually administered in the buttocks, and the dose may vary based on age, weight, and medical condition [3].
What are the potential side effects of testosterone cypionate 200 mg injection?
Common side effects of testosterone cypionate injection include acne, hair loss, increased body hair growth, and changes in libido [4]. More serious potential side effects include blood clots, prostate problems, and increased risk of heart attack and stroke [4]. Patients with a history of prostate cancer, severe urinary issues, or certain blood disorders should not take testosterone cypionate [5].
How long does testosterone cypionate 200 mg injection stay in the body?
The elimination half-life of testosterone cypionate is approximately 8-12 days, but its active metabolites can persist in the bloodstream for several weeks [6]. This means that testosterone levels may remain elevated for an extended period even after the last injection.
Who makes testosterone cypionate 200 mg injection?
Several pharmaceutical companies produce testosterone cypionate, including Teva Pharmaceutical Industries Ltd. and Sandoz Inc. [7].
When does the patent expire on testosterone cypionate 200 mg injection?
The United States Food and Drug Administration (FDA) approved testosterone cypionate in 1974. The patent for testosterone cypionate has expired, allowing generic versions to be manufactured and sold [8].
Can biosimilars enter the market before patent expiry?
Biosimilars can enter the market after the reference product (in this case, testosterone cypionate) loses its exclusivity, which is typically 20 years from the original approval date. However, the biosimilar manufacturer must demonstrate that its product is highly similar to the reference product through a regulatory approval process [9].
Sources:
[1] MedlinePlus. (2022). Testosterone Replacement Therapy.
[2] American Urological Association. (2019). Testosterone Therapy.
[3] WebMD. (n.d.). Testosterone Cypionate Injection.
[4] Drugs.com. (n.d.). Testosterone Cypionate Dosage and Side Effects.
[5] Mayo Clinic. (2020). Testosterone Replacement Therapy: Risks and Complications.
[6] ScienceDirect. (n.d.). Pharmacokinetics of Testosterone Cypionate.
[7] RxList. (n.d.). Teva Pharmaceutical Industries Ltd and Sandoz Inc.
[8] FDA.gov. (n.d.). Testosterone Cypionate Injection.
[9] BioPharma. (n.d.). Biosimilars: A Guide for Manufacturers.